The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| VASO | +19.53% | +210% | +25.39% | -95% |
| S&P | +12.94% | +86.25% | +13.25% | +1,565% |
Vaso Corp. engages in the healthcare equipment and information technology industries. It operates through the following segments: Information Technology (IT), Professional Sales Service, and Equipment. The IT segment focuses on healthcare IT and managed network technology services. The Professional Sales Service segment is involved in selling healthcare capital equipment. The Equipment segment consists of designing, manufacturing, selling, and servicing proprietary medical devices. The company was founded by John C. K. Hui and William Cross in July 1987 and is headquartered in Plainview, NY.
No news articles found for Vaso.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $22.66M | 9.1% |
| Gross Profit | $13.90M | 18.2% |
| Gross Margin | 61.33% | 4.7% |
| Market Cap | $20.91M | -37.1% |
| Market Cap / Employee | $0.07M | 0.0% |
| Employees | 298 | -0.7% |
| Net Income | $1.71M | 244.9% |
| EBITDA | $1.72M | 357.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $34.86M | 29.9% |
| Accounts Receivable | $9.17M | 12.3% |
| Inventory | 0.9 | -22.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.78M | -28.3% |
| Short Term Debt | $1.26M | 13.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.27% | 3.4% |
| Return On Invested Capital | 24.79% | 1.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $3.01M | 102.4% |
| Operating Free Cash Flow | $2.78M | 44.2% |
| Metric | Q2 2024 | Q4 2024 | Q1 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 23.05 | 22.20 | 24.58 | 8.10 | -51.18% |
| Price to Book | 0.82 | 0.92 | 0.85 | 0.79 | -36.55% |
| Price to Sales | 0.24 | 0.29 | 0.26 | 0.23 | -42.31% |
| Price to Tangible Book Value | 2.47 | 2.42 | 2.43 | 2.30 | -33.12% |
| Price to Free Cash Flow TTM | 11.52 | 10.44 | 3.62 | 2.69 | -94.68% |
| Enterprise Value to EBITDA | -1.14 | -2.19 | 30.31 | -6.93 | -130.20% |
| Free Cash Flow Yield | 8.7% | 9.6% | 27.6% | 37.2% | 1778.27% |
| Return on Equity | 3.5% | 4.0% | -1.1% | 9.6% | -2187.12% |
| Total Debt | $2.38M | $2.15M | $2.95M | $2.03M | -7.26% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
